First, to investigate whether ACE2 levels in the brain could be associated with cognitive dysfunction, we compared mRNA and protein levels of ACE2 in postmortem brain samples from individuals of two different cohorts, including subjects diagnosed with AD. This evidence concerns the gene ACE2 and Alzheimer disease.